Cell cycling in HIV infection: analysis of in vivo activated lymphocytes
- PMID: 8536361
- PMCID: PMC1553359
- DOI: 10.1111/j.1365-2249.1995.tb03841.x
Cell cycling in HIV infection: analysis of in vivo activated lymphocytes
Abstract
Infection with HIV results in increased circulating levels of T lymphocytes expressing phenotypic markers of immune activation. In the present study, using three-colour immunofluorescence, we examined the cell cycle status of these activated cells. Activated (HLA-DR+, CD25+ and CD38+) CD4+ and CD8+ T lymphocytes in peripheral blood were analysed for DNA content in 15 HIV+ patients and 10 healthy age- and sex-matched control subjects. As expected, all HIV+ patients had elevated percentage levels of activated CD4+ HLA-DR+, CD4+ CD25+, CD8+ HLA-DR+, CD8+ CD25+ and CD8+ CD38+ T lymphocytes compared with control subjects (P < 0.001 for all). Percentage levels of CD4+ HLA-DR+ and CD8+ HLA-DR+T lymphocytes in the 'proliferative' (S-G2M) phase of the cell cycle were also higher in the HIV+ patients compared with controls (P < 0.001 for both). The percentage levels of proliferative CD4+ CD25+, CD8+ CD25+ and CD8+ CD38+ lymphocytes were, however, similar in HIV+ patients and controls, indicating that the proliferative fraction of cells in vivo was confined to the HLA-DR+ subset and absent from the CD25+ and CD38+ populations. Four HIV+ patients had grossly elevated levels of CD8+ lymphocytes which were CD38+ (> 95%) and confined to the pre-G0-G1 phase of the cell cycle, suggesting these may be cells committed to apoptosis. These observations indicate an increase in the proliferative capacity of HLA-DR+ T lymphocytes in HIV infection in vivo. The reduced DNA content in other populations (e.g. CD38+ CD8+ lymphocytes) of some patients with advanced HIV disease suggests that these cells are apoptotic. Thus our results define both proliferative and apoptotic processes as a spectrum of activation-related events in HIV infection.
Similar articles
-
Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.Clin Exp Immunol. 1994 Mar;95(3):436-41. doi: 10.1111/j.1365-2249.1994.tb07015.x. Clin Exp Immunol. 1994. PMID: 7907956 Free PMC article.
-
During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.Clin Immunol Immunopathol. 1995 Oct;77(1):33-41. doi: 10.1016/0090-1229(95)90134-5. Clin Immunol Immunopathol. 1995. PMID: 7554481
-
Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):128-35. doi: 10.1097/00042560-199702010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052721
-
CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals.Chem Immunol. 2000;75:207-17. doi: 10.1159/000058770. Chem Immunol. 2000. PMID: 10851786 Review. No abstract available.
-
Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.Front Immunol. 2021 Jun 17;12:693269. doi: 10.3389/fimmu.2021.693269. eCollection 2021. Front Immunol. 2021. PMID: 34220854 Free PMC article. Review.
Cited by
-
Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins.J Exp Med. 1997 Apr 7;185(7):1381-6. doi: 10.1084/jem.185.7.1381. J Exp Med. 1997. PMID: 9104824 Free PMC article.
-
Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.Clin Exp Immunol. 1999 Mar;115(3):451-7. doi: 10.1046/j.1365-2249.1999.00806.x. Clin Exp Immunol. 1999. PMID: 10193417 Free PMC article.
-
A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.Clin Exp Immunol. 2000 Oct;122(1):72-8. doi: 10.1046/j.1365-2249.2000.01348.x. Clin Exp Immunol. 2000. PMID: 11012621 Free PMC article.
-
The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls.Eur J Immunol. 2012 Oct;42(10):2608-20. doi: 10.1002/eji.201142046. Epub 2012 Aug 6. Eur J Immunol. 2012. PMID: 22777759 Free PMC article.
-
Immune activation and viral replication after vaccination with an influenza A H1N1 2009 vaccine in HIV-infected children receiving antiretroviral therapy.Dis Markers. 2013;35(4):221-7. doi: 10.1155/2013/276547. Epub 2013 Sep 5. Dis Markers. 2013. PMID: 24167370 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials